PGHH Declares Interim Dividend of ₹195/share, Including ₹25 Special Dividend
PGHH declared an interim dividend of ₹195 per equity share for FY25-26, including a special ₹25 dividend, payable by Feb 27, 2026. The record date is Feb 5, 2026. For Q3 FY26, PGHH reported a profit after tax of ₹30,146 Lakhs and revenue from operations of ₹126,190 Lakhs.
The dividend declaration is a significant event for shareholders. The amount of the dividend and the inclusion of a special dividend component can positively influence investor sentiment and potentially impact the stock price. However, the financial results themselves are also a key factor.
The declaration of an interim dividend, especially with a special component, is generally viewed positively by investors as it indicates strong financial health and a commitment to returning value to shareholders.
Procter & Gamble Hygiene and Health Care Limited (PGHH) announced its unaudited financial results for the quarter ended December 31, 2025. The Board of Directors, in their meeting held on January 30, 2026, also declared an interim dividend for the Financial Year 2025-26.
The interim dividend amounts to ₹195 per equity share, which includes a one-time special dividend of ₹25 per equity share. This dividend will be paid on or before February 27, 2026. The record date for determining the eligibility for this dividend payment has been fixed as February 5, 2026.
The company's financial results for the quarter ended December 31, 2025, showed a profit after tax of ₹30,146 Lakhs. For the nine months ended December 31, 2025, the profit after tax stood at ₹70,337 Lakhs. Revenue from operations for the quarter was ₹126,190 Lakhs, and for the nine months, it was ₹334,910 Lakhs.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.